Lobbying client · LD-2 disclosures
Biopharmaceutical Research Company
California
3 filings from 1 registrant · 2018–2019 · latest filed Apr 15, 2019
Reported on its behalf
$0
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$0
none reported
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who did the lobbying
Every lobbyist named on this client's filings.
- Ronald Eritano The Normandy Group, LLCCovered position: LegCorr.SenLautenberg/LegAsst.RepDoggett1 filingthrough 2018
- John Goldberg The Normandy Group, LLCCovered position: : Science Advisor House Ag Committee (1994-2016)1 filingthrough 2018
- Jim Kiley The Normandy Group, LLC1 filingthrough 2018
Covered positions · 2 of 3 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: biopharmaceutical-research-company.